Latent autoimmune diabetes in adults: an update.
- Author:
Zhi-guang ZHOU
1
;
Xia LI
Author Information
1. Institute of Metabolism and Endocrinology, Xiangya Second Hospital, Central South University, Changsha 410011, China. zhouzg@hotmail.com
- Publication Type:Journal Article
- MeSH:
Adult;
Autoantibodies;
blood;
Diabetes Mellitus, Type 1;
classification;
diagnosis;
drug therapy;
Humans;
Insulin;
therapeutic use;
Islets of Langerhans;
immunology
- From:
Acta Academiae Medicinae Sinicae
2003;25(5):630-634
- CountryChina
- Language:Chinese
-
Abstract:
Latent autoimmune diabetes in adults (LADA), presenting with a similar phenotype of type 2 diabetes at early stage, belongs to the slowly progressive subtype of autoimmune type 1 diabetes. LADA differs from classic juvenile-onset type 1 diabetes in which its autoimmune destructive process of islet beta-cells is much slower, so LADA may serve as a human model of autoimmune type 1 diabetes. Although no international standardized criteria for the diagnosis of LADA has been established, it should be noted that LADA has some specific features in clinical characteristics, susceptible genotypes, cellular and humoral immune markers, as well as islet pathology. Presence of islet autoantibodies is necessary for the diagnosis of LADA. Early insulin intervention may preserve residual islet beta-cell function in LADA. The different pathological manifestations of LADA with different autoantibody titers can help throw light on the autoimmune process, laying foundation of prevention or even cure of type 1 diabetes.
